Get started
Author

Nathan De Beule

Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group
2003 · K. Hoang-Xuan, L. Taillandier, et al. · Journal of Clinical Oncology · 267
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972
2003 · M.J. van den Bent, O. Chinot, et al. · Annals of Oncology · 165
PDF
The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells
2015 · Jinheng Wang, Kim De Veirman, et al. · Oncotarget · 153
PDF
Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells
2015 · Kim De Veirman, Jo A. Van Ginderachter, et al. · Oncotarget · 70
PDF
Tumour‐associated macrophage‐mediated survival of myeloma cells through STAT3 activation
2016 · Nathan De Beule, Kim De Veirman, et al. · The Journal of Pathology · 69
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway
2018 · Kim De Veirman, Eline Menu, et al. · Cancer Letters · 60
Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion
2017 · Kim De Veirman, Nathan De Beule, et al. · Cancer Immunology Research · 57
AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma
2019 · Siyang Yan, Niels Vandewalle, et al. · Cancers · 32
PDF
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
2023 · Rong Fan, Hatice Satilmis, et al. · Journal for ImmunoTherapy of Cancer · 27
PDF
The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
2022 · Rong Fan, Nathan De Beule, et al. · Frontiers in Immunology · 27
PDF
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia
2023 · Rong Fan, Hatice Satilmis, et al. · Blood Cancer Journal · 18
PDF
Targeting the β 2 ‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism
2022 · Hatice Satilmis, Emma Verheye, et al. · The Journal of Pathology · 17
PDF
AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies
2024 · Niels Vandewalle, Nathan De Beule, et al. · Experimental Hematology and Oncology · 13
PDF
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
2024 · Niels Vandewalle, Hatice Satilmis, et al. · Theranostics · 10
PDF
The de novo DNA methyltransferase 3B is a novel epigenetic regulator of MYC in multiple myeloma, representing a promising therapeutic target to counter relapse
2025 · Catharina Muylaert, Lien Ann Van Hemelrijck, et al. · Journal of Experimental & Clinical Cancer Research · 7
PDF
Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells
2017 · Nathan De Beule, Eline Menu, et al. · Oncotarget · 5
PDF
Real‐life data of luspatercept in lower‐risk myelodysplastic syndromes advocate new research objectives
2024 · Bert Heyrman, Stef Meers, et al. · eJHaem · 4
PDF
Myeloid Derived Suppressor Cell Mediated AMPK Activation Regulates Multiple Myeloma Cell Survival
2014 · Kim De Veirman, Jo A. Van Ginderachter, et al. · Blood · 3
Successful Treatment of Very Severe Sinusoidal Obstruction Syndrome After Gemtuzumab Ozogamicin With Transjugular Intrahepatic Portosystemic Shunt, Defibrotide, and High-Dose Corticosteroids: A Case Report
2024 · Naomi Thielemans, Nathan De Beule, et al. · Cureus · 2
PDF
Unexpected Murmur after Percutaneous Left Atrial Appendage Occlusion
2018 · Xavier Galloo, Nathan De Beule, et al. · Structural Heart · 2
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Series and Review of Literature
2025 · Shula Staessens, Nathan De Beule, et al. · Cureus · 1
PDF
Long-Term Survival and Quality of Life Analysis after Autologous Stem Cell Transplantation for Lymphoma
2016 · Sylvia Faict, Nathan De Beule, et al. · Blood · 1
Targeting S100A9 Interactions in the Multiple Myeloma Bone Marrow Environment Reduces Angiogenesis and Tumor Growth
2016 · Kim De Veirman, Els Van Valckenborgh, et al. · Blood · 1
Bone Marrow Stromal Cell-Derived Exosomes Facilitate Multiple Myeloma Cell Survival Through Inhibition Of The JNK Pathway
2013 · Jinheng Wang, An Hendrix, et al. · Blood · 1
Intravascular Large B-cell Lymphoma Associated With Hemophagocytosis as a Cause of Fever of Unknown Origin: A Review of Literature
2024 · Shula Staessens, Nathan De Beule, et al. · Cureus
PDF
Works count: 50
Citation count: 1,012
H-index: 13
I10-index: 14
Year
Topic
Type